Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Cellestia Biotech AG

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

5

Active:3

Completed:0

Trial Phases

1 Phases

Phase 1:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1

4 (100.0%)

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Phase 1

Terminated

Conditions: Non-hodgkin Lymphoma
Hepatocellular Carcinoma
Breast Cancer
Adenoid Cystic Carcinoma
Osteosarcoma
Colorectal Cancer
Glomus Tumor, Malignant
T-ALL

Interventions: Drug: CB-103

First Posted Date: 2018-02-06

Last Posted Date: 2024-01-16

Lead Sponsor: Cellestia Biotech AG

Target Recruit Count: 79

Registration Number: NCT03422679

Locations: 🇺🇸
Sarcoma Oncology Research Center, Santa Monica, California, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
MD Anderson, Houston, Texas, United States

and more 13 locations

News

No news found

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy